Cerebral proton spectroscopy in patients with human immunodeficiency virus infection;Espectroscopia de protón en el cerebro de personas infectadas por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 107, Issue 10, 1996, Pages 361-365

  Alonso, J ^a   Rovira, A ^a   Capellades, J ^a   Ocana I ^b   Rio J ^b   Wicklow, K ^c   Sauter, R ^c   Gili, J ^a  

^a Institut de Diagnostic per la Imatge   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c SIEMENS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; SPECTROMETRY;

ADULT; BRAIN DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPECTROMETRY, X-RAY EMISSION;

EID: 0030604838     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bottomley PA. Human in vivo NMR spectrescopy in diagnostic medicine: clinical tool or research probe? Radiology 1989; 170: 1-15.
2. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994; 241: 354-371.
3. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Quart 1994; 10: 191-247.
4. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localised high-resolution proton NMR spectroscopy using stimulated echoes. Initial applications to human brain in vivo. Magn Reson Med 1989; 9: 79-93.
5. Nadler JV, Cooper JR. N-Acetyl-L-Aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J Neurochem 1972; 19: 313-319.
6. 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989; 13: 23-31.
7. Menon DK, Baudouin CJ, Tomlinson D, Hoyle C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr 1990; 14: 882-885.
8. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA et al. Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992; 16: 538-542.
9. 1H magnetic resonance spectroscopic imaging. Neurology 1993; 43: 509-515.
10. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993; 186: 739-744.
11. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993; 188: 119-124.
12. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists. AIDS program, Center for Infectious Diseases. Morb Mortal Wkly Rep 1987; 36 (Supl 1): 1-15.
13. Folstein MF, Folstein SE, McHugh PR. Mini-Mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
14. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508: 333-348.
15. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985; 30: 341-344.
16. Ordidge RJ, Creshull ID. The correction of transient BO field shifts following the application of pulsed gradients by phase correction in the time domain. J Magn Reson 1986; 69: 151-155.
17. Petroff OAC, Graham GD, Blamire AM, Al-Rayess M, Rothman DL, Fayad PB et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 1992; 42: 1.349-1.354.
18. Richards TL. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. Am J Roentgenol 1991; 157: 1.073-1.078.
19. Everall IP, Luthert PJ, Lantos PL. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 1993; 56: 481-486.
20. Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. En: Price RW, Perry SW, editores. HIV, AIDS and the Brain. Nueva York: Raven Press, 1994; 1-45.
21. Maj M, Janssen R, Satz P, Zaudig M, Starace F, Boor D et al. The World Health Organization's cross-cultural study on neuropsychiatric aspects of infection with the human immunodeficiency virus 1 (HIV-1). Br J Psychiatr 1991; 159: 351-356.